Systemic lupus erythematosus (SLE) is a disease with varied manifestations involving multiple organ systems, accompanied by multiple laboratory abnormalities, and characterized by exacerbations and remissions. Noting that 'uniform classification of defined groups of patients is necessary in order to assemble and compare data from different sources concerning natural history, evaluation of therapy, and epidemologic description', the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association recently approached the formidable task of assembling criteria for the classification of SLE (Cohen, Reynolds, Franklin, Kulka, Ropes, Shulman, and Wallace, 1971) . To increase the utility of the criteria in population studies, the use of 'exclusions' and 'duration of manifestations' was avoided. A distinction between 'major' and 'minor' criteria was also not used. Thus, the form of these criteria differs from that of the Jones Criteria for Rheumatic Fever and the ARA Criteria for Rheumatoid Arthritis (Arthritis Foundation, 1964) .
The committee collected a data base of 245 patients with unequivocal SLE, 234 patients with rheumatoid arthritis, and 217 patients with miscellaneous nonrheumatic diseases. Data was contributed by 52 investigators throughout the United States, who were requested to submit patients with 'unequivocal' SLE, and with 'classic' or 'definite' rheumatoid arthritis. Patients whose clinical course was atypical or in whom diagnostic uncertainty remained were excluded from these two groups.
Data was sought on 74 variables of disease considered of potential value for classification. Adequate data was obtained on 57 potential criteria, and the list was reduced to 21 by exclusion of variables which were least useful in distinguishing patients with 'SLE' from 'RA' and 'other' diseases. The Medical Centers. LE-cell tests are not available for all our patients and we have modified the eighth criterion to include either a positive LE-cell preparation or a positive fluorescent antinuclear antibody at a titre of 1:20 or greater. This weakens the performance of the criteria, and data are presented both with the original criteria and with the modified eighth criterion.
Programs were written in PL/ACME, a subset of IBM language PL/l, for use with our databank in an IBM 360/50 digital computer. Each patient in the databank was analysed with regard to the number of positive criteria and to the particular criteria which were positive. The population was first surveyed for positive criteria occurring at any time in the patient course. Secondly, a survey was made of findings at the time of the first visit. Thirdly, assessment of one thousand patient-visits (other than the first) was made to ascertain the frequency with which criteria were positive at a random point in the disease course. Computer programs to determine interdependence of variables, and to simulate patient populations, were written with the same system.
Results
Table II compares the 'unequivocal SLE' population of the committee with SLE patients drawn from three single universities-the Stanford databank population used in this study, a large group of 520 patients reported by DuBois and Tuffanelli (1964) , and a recent series reported by Estes and Christian (1971) . Interestingly, the call for 'unequivocal' patients in the ARA group led to a very high frequency of positive LE-cell preparations (91 per cent.), butterfly rash (64 per cent.), and photosensitivity (37 per cent.). Similarly, the ARA Rheumatoid Arthritis group was characterized by a very high frequency of deformity (90 per cent.) and rather low frequencies of nonarthritic manifestations (leukopenia, positive LE-cell preparations, Raynaud's phenomenon, pleurisy). The majority of our rheumatoid arthritis patients do not to date have deforming arthritis, and the other manifestations are less unusual.
The preliminary criteria perform less well in less classic populations, as shown in Table III later patient visit are allowed. These differences obtain partly because of a failure of the physician specifically to identify all criteria at a single patient visit, partly because of suppression of some manifestations by therapy, and partly because relatively few of the criteria are present at the same point in time. A similar trend is present in our rheumatoid arthritis and scleroderma patient populations; the number of false positives decreases when more limited observation periods are used. These findings emphasize that the number of 'positives' in truly similar populations can vary widely depending upon the duration of follow-up available, or on whether the reporting institution emphasizes referral evaluations or continued long-term care. The slightly lower frequency of positive findings in our databank population compared with other reported patient populations probably reflects this same phenomenon, since our follow-up period is somewhat shorter. In general, individual criteria are most effective if they are completely independent ofother criteria; they are less efficient to the extent that several criteria measure the same aspect of the disease. Since a disease may be regarded as the common cause of its symptoms, it might be expected that all manifestations of the disease would be somewhat interrelated, and linked on the basis of disease severity.
Interdependence of parameters may be measured, using the computer databank. Table V 
